BOO and DU and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
Prevalence Rates of Bladder Outlet Obstruction and Detrusor Underactivity and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
1 other identifier
observational
455
0 countries
N/A
Brief Summary
Prevalence rates of bladder outlet obstruction (BOO) and detrusor underactivity (DU) and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation. Thus, the aim of this study was to elucidate the above findings and between-group associations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2018
CompletedFirst Submitted
Initial submission to the registry
July 18, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedAugust 3, 2018
July 1, 2018
6.9 years
July 18, 2018
August 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
BOO
Bladder outlet obstruction: Qmax was \<12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.
November 2011 to January 2017
DU
Detrusor underactivity: \<12 mL/s and PdetQmax was \<10 cmH2O
November 2011 to January 2017
Study Arms (3)
Bladder outlet obstruction (BOO)
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having BOO when Qmax was \<12 mL/s and PdetQmax was ≥25 cmH2O with sustained detrusor contraction during voiding cystometry.
Detrusor underactivity (DU)
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. Woman were defined as having DU when Qmax was \<12 mL/s and PdetQmax was \<10 cmH2O during voiding cystometry.
ND BOO/DU
Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent 20 min pad testing and urodynamic studies in a medical center were reviewed. This group revealed no demonstrated bladder outlet obstruction nor detrusor underactivity.
Interventions
20-minutes pad test and urodynamic study including uroflowmetry, filling cystometry and voiding cystometry.
Eligibility Criteria
Women with more than stage II cystocele
You may qualify if:
- Age \> 20y/o
- Cystocele \> stage II
- Complete pad test and urodynamic study
You may not qualify if:
- Pregnancy
- Urinary tract infection
- Had received pelvic reconstruction surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2018
First Posted
August 3, 2018
Study Start
January 1, 2011
Primary Completion
November 30, 2017
Study Completion
May 31, 2018
Last Updated
August 3, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share
No plan to share IPD